ZBIO
Zenas BioPharma, Inc.
27.50$
-7.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -100.0% | – | – | – | – | +100.0% | -100.0% | – | – | -100.0% | – | – | |
| – | +78,430.8% | +10.9% | +49.3% | -0.8% | -99.9% | -30.3% | +186,973.9% | -88.4% | +1,014.4% | -100.0% | – | – | |
| – | -140.8% | – | – | – | – | +100.0% | -530.3% | – | – | – | – | – | |
| – | +118.3% | +10.9% | +49.3% | -0.8% | +46.6% | -29.0% | +23.2% | -20.0% | +546.5% | -72.8% | +4.1% | – | |
| – | -17.2% | +18.6% | +8.5% | +35.5% | +58.1% | +8.3% | -8.7% | +16.3% | +29.7% | -1.1% | -6.9% | – | |
| – | -69.7% | +13.1% | +19.5% | +26.4% | +713.3% | -21.9% | -74.4% | +292.1% | +283.1% | -57.6% | +40.5% | – | |
| – | -169.6% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +55.4% | – | |
| – | -168.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -147.8% | – | – | – | – | – | – | |
| – | -169.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -168.1% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.